IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Relationship between 1,25Dihydroxycholecalciferol and Obesity

Author: LEANAALAA ABBAS, SAADMERZAH HUSSEIN, WATHIQESSAM HAMEED
Abstract: To show the association between1,25 dihydroxycholecalciferol and its effect on obesity. Background. One of the top worldwide health problems are overweight and obesity, it has reached pandemic proportions, with at least 2.8 million people dying each year as a result of being overweight or obese.In 2016,more than 1.9 billion adults, aged (18 years and older) were overweight, of these more than 650 million adults were obese. Many causes have been implicated for developing obesity such as: lack of physical activity,excessive food intake, genetic susceptibility, endocrine disorders, mental disorder, ormedications.Material and methods: One hundred andfive person were participated in this study visiting Al-Imam Al-Sadiq Teaching Hospital from October 2017 to June 2018. A 50 normal non-obese, and 55 obese. They were classified according to body mass index after measuring their weight, height, The Berlin Questionnaire was done for all patients and controls for diagnosis excluded disease and any treatment that effect on obesity. Blood and data were collected from patients and control to detectedVitamin D. Results:the highest percentage of obese patients were recorded among 20-30 age group, the majority of the obese patients were from urban areas, graduated from secondary school, unemployed. Regarding investigation: vitamin D, there is no significant difference (p value ? 0.05) between patients and controls for vitamin D, also no significant correlation between vitamin D and BMI (r = 0.04, P = 0.787), waist circumference (r = 0.006, P = 0.967), waist hip ratio (r = -0.1, P = 0.495). Conclusion:there is no significant association between obesity and vitamin D.
Keyword: Obesity, 1,25 Dihydroxycholecalciferol, Body Mass Index.
DOI: https://doi.org/10.31838/ijpr/2019.11.02.079
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477